Disparities in hypertension and cardiovascular disease in blacks: The critical role of medication adherence by Ferdinand, Keith C. et al.
University of Nebraska - Lincoln
DigitalCommons@University of Nebraska - Lincoln
Food and Drug Administration Papers U.S. Department of Health and Human Services
2017
Disparities in hypertension and cardiovascular
disease in blacks: The critical role of medication
adherence
Keith C. Ferdinand
Tulane University School of Medicine, kferdina@tulane.edu
Kapil Yadav
Tulane University School of Medicine
Samar A. Nasser
The George Washington University
Helene D. Clayton-Jeter
Food and Drug Administration
John Lewin
Lewin and Associates LLC
See next page for additional authors
Follow this and additional works at: http://digitalcommons.unl.edu/usfda
Part of the Dietetics and Clinical Nutrition Commons, Health and Medical Administration
Commons, Health Services Administration Commons, Pharmaceutical Preparations Commons, and
the Pharmacy Administration, Policy and Regulation Commons
This Article is brought to you for free and open access by the U.S. Department of Health and Human Services at DigitalCommons@University of
Nebraska - Lincoln. It has been accepted for inclusion in Food and Drug Administration Papers by an authorized administrator of
DigitalCommons@University of Nebraska - Lincoln.
Ferdinand, Keith C.; Yadav, Kapil; Nasser, Samar A.; Clayton-Jeter, Helene D.; Lewin, John; Cryer, Dennis R.; and Senatore, Fortunato
Fred, "Disparities in hypertension and cardiovascular disease in blacks: The critical role of medication adherence" (2017). Food and
Drug Administration Papers. 28.
http://digitalcommons.unl.edu/usfda/28
Authors
Keith C. Ferdinand, Kapil Yadav, Samar A. Nasser, Helene D. Clayton-Jeter, John Lewin, Dennis R. Cryer, and
Fortunato Fred Senatore
This article is available at DigitalCommons@University of Nebraska - Lincoln: http://digitalcommons.unl.edu/usfda/28
J Clin Hypertens. 2017;1–10.	 wileyonlinelibrary.com/journal/jch	 	 | 	1©2017 Wiley Periodicals, Inc.
 
Received:	19	March	2017  |  Revised:	21	May	2017  |  Accepted:	22	May	2017
DOI: 10.1111/jch.13089
R E V I E W  P A P E R
Disparities in hypertension and cardiovascular disease in 
blacks: The critical role of medication adherence
Keith C. Ferdinand MD1  | Kapil Yadav MD1 | Samar A. Nasser PhD, MPH, PA-C2 |  
Helene D. Clayton-Jeter OD3 | John Lewin MD4 | Dennis R. Cryer MD5 |  






























































afflicted	 by	 poor	 adherence	 to	 cardiovascular	 medications,	 such	 as	
angiotensin-	converting	enzyme	inhibitors,	β-	blockers,	and	statins,8-12 




A	 retrospective	 study	 evaluated	 hypertension	 registries	 in	 an	
inner-	city	healthcare	delivery	system	(N=17	176)	and	a	health	mainte-
nance	organization	(N=94	297)	to	develop	clinical	prediction	rules	for	
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adherence	with	antihypertensive	medications.15	In	these	populations,	
only	 36%	of	 the	 total	 number	 of	 patients	were	 adherent.	Adherent	
patients	were	 likely	 to	be	older,	white,	married,	 and	 acculturated	 in	
US	 society;	 to	have	diabetes	mellitus	or	 cerebrovascular	disease;	 to	
not	 abuse	 alcohol	 or	 controlled	 substances;	 and	 to	 be	 prescribed	
fewer	 than	 three	 antihypertensive	 medications.	 Although	 sociode-
mographic	characteristics	or	clinical	diagnoses	were	statistically	asso-
ciated	with	adherence,	 the	combination	of	these	characteristics	was	

























in	 inadequate	BP	control	 in	 all	 populations,	 there	 are	 several	phy-




ence	 issues,	 emphasizing	 the	 importance	 of	 maintaining	 routines,	
discussing	belief	systems	and	barriers	that	stand	between	patients	
and	 effective	 BP	 control.	 Team-	based	 care	 involving	 nonphysician	





ease	 and	 stroke	 each	 year	 are	 preventable,	 and	 blacks	 are	 nearly	




of	 these	unacceptable	 gaps	 in	morbidity	 and	mortality,	 absent	 sig-
nificant	biologic	explanation,	it	is	beneficial	to	focus	on	the	potential	










medication	 adherence	 in	 support	 of	 a	 critical	 public	 health	mission:	
decreasing	 CVD	 among	 subpopulations	 and	 high-	quality	 monitor-
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belief	 assessments	may	 assist	with	 identifying	 discordant	 beliefs.	 A	
systematic	review	of	22	studies,	including	6516	participants,	demon-
strated	that	the	perception	by	blacks	that	hypertension	was	episodic	




Between	 2002	 and	 2013,	 person-	centered	 care	 disparities	 in	
patients	who	 reported	poor	 communication	with	healthcare	provid-
ers	 persisted	 and	were	 driven	 by	 race	 and	 financial	 income	despite	
an	overall	trend	in	improvement	(Figure	4).	The	percentage	of	adults	





Socioeconomic	 status	 has	 a	 profound	 impact	 on	 CVD	 morbid-
ity,	mortality,	 and	medication	 adherence.	Among	 the	 7.8%	of	US	
adults	 who	 did	 not	 take	 their	 medication	 as	 prescribed	 to	 save	
money,	 the	poorest	adults	were	most	 likely	 to	be	nonadherent.24 
The	 geographic	 distribution	 of	 preventable	 death	 from	 CVD	 and	
stroke	was	skewed	with	significantly	higher	death	in	southeastern	
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correlated	with	Centers	for	Disease	Control	and	Prevention	socio-





uninsured	 people	 who	 gained	 private	 coverage	 filled,	 on	 average,	
28%	 more	 prescriptions	 and	 had	 29%	 less	 out-	of-	pocket	 spending	
per	prescription.25	Therefore,	for	chronic	conditions,	access	to	health	
insurance	appeared	to	reduce	financial	barriers	to	care	and	 increase	













4  | PRACTICAL APPROACHES TO 
ADDRESS MEDICATION ADHERENCE 
WITH THE POTENTIAL TO ADDRESS 
RACIAL DISPARITIES
4.1 | Patient engagement to address disparities and 
nonadherence
Adherence	 improves	 when	 providers	 engage	 patients	 in	 their	
health	 care,	 and	 patients	 are	 better	 educated,	 informed,	 and	 in-
teractive	 in	 making	 healthcare	 decisions	 best	 suited	 to	 them.29 
However,		patient	engagement	may	be	a	more	difficult	goal	among	
minorities.30
In	 the	 modern	 era	 of	 transparent,	 patient-	centered	 medicine	
and	 shared	 decision	 making,	 indications-	based	 prescribing	 has	
multiple	potential	benefits,	including,	but	not	limited	to,	improving	
medication	safety	and	enhanced	healthcare	team	communication.31 
Patients	 who	 have	 optimal	 knowledge	 about	 their	 medications	
demonstrate	 better	 adherence	 and	 fewer	 errors.32 To enhance 
knowledge,	 the	 US	 Food	 and	 Drug	 Administration’s	 efforts	 are	
	focused	on	ways	in	which	regulatory	strategies,	labeling,	and	patient	
information	 can	 interdigitate	 with	 healthcare	 delivery	 to	 improve	
medication	adherence.28
4.2 | Consumer- directed health care: an 
emerging concept
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and	 making	 smarter	 decisions	 when	 accessing	 healthcare	 services.	
Insurers	or	employers	make	available	evidence-	based	drugs	 at	 little	
or	no	cost.	In	a	retrospective	observational	study	of	employees	from	




cardiovascular	 medication	 adherence	 was	 9.4%	 higher.33	 Based	 on	
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4.3 | Patient portals and electronic health records
Increasingly,	 electronic	 health	 records	 feature	 patient	 portals	 that	
allow	 patients,	 among	 many	 other	 options,	 to	 request	 prescription	
refills,	 saving	 time	 and	 money.34	 Overall,	 limited	 access	 to	 a	 per-
sonal	computer	or	means	to	connect	with	the	internet	for	utilization	





4.4 | Smartphone apps and text messages
For	many	patients,	routine	text	messaging	may	be	considered	to	en-
hance	adherence.	 In	a	meta-	analysis	of	 randomized	controlled	 trials	
published	 between	 2005	 and	 2008,	 eight	 of	 nine	 interventions	 for	
disease	 prevention	 and	management	 showed	 a	 positive	 short-	term	
effect	utilizing	some	form	of	automated	reminders.	Clearly,	text	mes-
saging	and	mobile	health	technologies	represent	a	unique	opportunity	
to	 enhance	medication	 adherence	 and	 healthcare	 outcomes.	 A	 key	




tematic	 review,	 digital	 health	 interventions,	 including	 mobile	 apps	
were	 significantly	 associated	 with	 improved	 CVD	 outcomes.35 The 
main	 challenges	 to	 increase	 adherence	 and	 reduce	 disparities	 with	
these	novel	tools	are	ease	of	use,	costs,	and	adoption	by	blacks	and	








hypertension	 to	 take	 their	medication	 by	 emitting	 light	 and	 sound,	




patient	 adherence.	 Physician-	pharmacist	 collaboration	 improves	 BP	
including	 patients	 with	 low	 incomes,	 those	 receiving	 Medicaid,	 or	
those	without	insurance.	In	a	recent	trial	involving	32	medical	offices	
in	15	states,	a	clinical	pharmacist	was	embedded	within	each	office	
























A	promising	 approach	 is	 the	 use	 of	 cognitive-	based	 behavior	 strat-
egies	such	as	motivational	 interviewing.41	Motivational	 interviewing	
is	direct,	patient-	centered	counseling	designed	to	stimulate	patients	













health	 care,	 patient	 portals,	 smartphone	 apps,	 digital	 pillboxes	 and	
pill	 bottles,	 pharmacist-	led	 engagement,	 cardiac	 rehabilitation,	 and	
cognitive-	based	behavior.	All	of	the	aforementioned	new	and	emerg-
ing	strategies	and	technologies	must	also	be	designed	to	ensure	cul-
tural	 acceptability,	 accessibility,	 and	clinical	 effectiveness	across	 the	
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